4.3 Lower GI Toxicities: Diarrhea, Radiation Enteritis, & Constipation
Key Takeaways
- Irinotecan induces dual lower GI toxicities: acute cholinergic diarrhea (<24 hours post-infusion, managed with IV/SQ atropine) and delayed secretomotor diarrhea (>24 hours, driven by SN-38 mucosal damage, managed with high-dose loperamide).
- Common Terminology Criteria for Adverse Events (CTCAE v5.0) Grade 3 diarrhea is defined by an increase of >=7 stools per day over baseline, incontinence, or limitation in self-care ADLs requiring hospitalization or IV fluids.
- Radiation enteritis occurs in acute form (during therapy, crypt cell mitotic arrest, managed with low-fat, low-lactose, low-insoluble fiber diet) and chronic form (>6 months post-RT, obliterative endarteritis, submucosal fibrosis, strictures, requiring peptide EN or TPN).
- Post-gastrectomy Dumping Syndrome is classified into Early Dumping (10-30 min, hyperosmolar fluid shifts, dizziness, cramps) and Late Dumping (1-3 hours, rapid glucose absorption causing reactive hypoglycemia); managed by small dry meals, simple sugar restriction, liquid separation by 30-60 min, and soluble pectin fiber.
4.3 Lower GI Toxicities: Diarrhea, Radiation Enteritis, & Constipation
Lower gastrointestinal toxicities resulting from antineoplastic chemotherapy agents, pelvic or abdominal radiation therapy, and surgical resections present severe challenges in oncology care. Uncontrolled diarrhea, mucosal malabsorption, radiation enteropathy, and severe constipation put patients at immediate risk for severe dehydration, hemodynamic instability, electrolyte exhaustion (hypokalemia, metabolic acidosis), acute kidney injury, and rapid malnutrition.
Chemotherapy-Induced Diarrhea (CID)
CID is most commonly caused by fluoropyrimidines (5-Fluorouracil [5-FU], Capecitabine) and Irinotecan (CPT-11), as well as targeted tyrosine kinase inhibitors (TKIs like lapatinib, afatinib, and neratinib).
Irinotecan Dual-Mechanism Toxicity Protocol
Irinotecan produces two pathophysiologically distinct types of diarrhea that require completely different pharmacological interventions:
- Acute Cholinergic Diarrhea (<24 hours post-infusion): Caused by direct inhibition of acetylcholinesterase by the irinotecan parent compound, leading to systemic cholinergic excess. Manifests with abdominal cramping, diaphoresis, hyper-salivation, lacrimation, miosis, and watery diarrhea. Treatment: Intravenous or Subcutaneous Atropine (0.25 to 1.0 mg).
- Delayed Secretomotor Diarrhea (>24 hours post-infusion, peaking at Days 3–5): Caused by the active lipophilic metabolite SN-38. Glucuronidated in the liver to inactive SN-38G, it is excreted into bile where intestinal $\beta$-glucuronidase enzymes reconvert it back to toxic free SN-38. Free SN-38 causes mucosal denudation, enterocyte apoptosis, mucosal inflammation, and massive hypersecretion of water and electrolytes. Treatment: Aggressive High-Dose Loperamide Protocol.
CTCAE v5.0 Diarrhea Grading System
| CTCAE Grade | Clinical Criteria & Stool Frequency |
|---|---|
| Grade 1 | Increase of <4 stools/day over baseline; mild increase in ostomy output relative to baseline. |
| Grade 2 | Increase of 4 to 6 stools/day over baseline; moderate increase in ostomy output; limiting instrumental ADLs. |
| Grade 3 | Increase of $\ge 7$ stools/day over baseline; incontinence; limiting self-care ADLs; hospitalization or IV fluids required. |
| Grade 4 | Life-threatening consequences; urgent intervention indicated (hypovolemic shock, severe electrolyte collapse, sepsis). |
| Grade 5 | Death. |
High-Dose Loperamide & Second-Line Protocols
- Loperamide Protocol: At the very first unformed stool, the patient takes 4 mg of oral loperamide, followed by 2 mg every 2 hours (or 4 mg every 4 hours during sleep) until the patient is completely free of diarrhea for 12 consecutive hours. Package label maximums (16 mg/day) are safely exceeded under medical oversight during CID.
- Second-Line Pharmacotherapy: If diarrhea persists beyond 24–48 hours despite high-dose loperamide, initiate Octreotide (100 to 500 mcg SubQ or IV TID). Octreotide is a somatostatin analog that inhibits gastrointestinal hormone secretion, reduces intestinal motility, and drastically decreases fluid and electrolyte secretion.
Radiation Enteritis & Colitis
Ionizing radiation to abdominal or pelvic fields (cervical, prostate, rectal, pancreatic cancers) damages rapidly proliferating intestinal crypt stem cells.
| Feature | Acute Radiation Enteritis | Chronic / Late Radiation Enteritis |
|---|---|---|
| Onset | During therapy or within 1 to 6 weeks of radiation completion | >6 months to years (or decades) post-radiation |
| Pathophysiology | Crypt cell mitotic arrest, villous atrophy, acute mucosal inflammation, hypermotility | Progressive obliterative endarteritis, submucosal ischemia, collagen deposition, fibrosis, strictures, fistulae, short bowel syndrome |
| Malabsorptive Profile | Transient lactose intolerance, bile acid malabsorption, hypermotility | Permanent fat, protein, $B_{12}$, and fat-soluble vitamin malabsorption; bacterial overgrowth (SIBO); intestinal obstruction |
| MNT Recommendations | Low-fat (<20% kcal), low-lactose, low-insoluble fiber, high soluble fiber (pectin, psyllium), Oral Rehydration Solutions (ORS) | Tailored enteral nutrition (elemental/peptide-based), low-fat diet, MCT oil, Parenteral Nutrition (PN) for strictures/obstruction |
Post-Gastrectomy & Post-Surgical Dumping Syndrome
Surgical procedures such as total or subtotal gastrectomy, Roux-en-Y reconstruction, or Whipple procedures destroy or bypass pyloric sphincter regulation, resulting in rapid delivery of hyperosmolar chyme into the proximal jejunum.
Surgical Resection / Pyloric Loss
│
▼
Rapid Bolus of Hyperosmolar Chyme into Jejunum
│
├─────────────────────────────────────────┐
▼ ▼
Early Dumping (10-30 min) Late Dumping (1-3 hours)
• Massive Intravascular Fluid Shift • Rapid Intestinal Glucose Absorption
• Intestinal Lumen Distension • Exaggerated Insulin Surge
• Cramps, Diarrhea, Tachycardia • Reactive Hypoglycemia
• Orthostatic Hypotension • Diaphoresis, Tremors, Confusion
MNT Protocol for Dumping Syndrome
- Consume 6 to 8 small, dry meals daily.
- Strictly restrict simple sugars and refined carbohydrates (table sugar, candy, fruit juices, sodas) to prevent hyperosmolar shifts and hyperinsulinemia.
- Separate liquid intake from solid foods by 30 to 60 minutes (consume completely dry meals to prevent flushing chyme into the bowel).
- Supplement meals with soluble viscous fiber (pectin, guar gum, psyllium) to increase chyme viscosity, delay gastric emptying, and slow glucose absorption.
- Recline or lie recumbent for 20 to 30 minutes post-meal to reduce gravity-driven intestinal transit.
Constipation & Paralytic Ileus in Supportive Oncology
Constipation in cancer patients stems from opioid analgesics, 5-HT3 antiemetics, vinca alkaloids (Vincristine, Vinblastine), dehydration, hypercalcemia, and immobility.
- Vinca Alkaloid Neurotoxicity: Vincristine causes direct damage to the autonomic myenteric plexus, leading to paralytic ileus, severe colonic impaction, and pseudo-obstruction.
- Pharmacological Management: Combine a bowel stimulant (Senna, Bisacodyl) with an osmotic laxative (Polyethylene Glycol [Miralax], Lactulose). For Refractory Opioid-Induced Constipation (OIC), utilize Peripherally Acting Mu-Opioid Receptor Antagonists (PAMORAs like Methylnaltrexone or Naloxegol), which reverse constipation without neutralizing central analgesia.
Clinical Calculation & Worked Case Example
Patient Profile: A 64-year-old male receiving FOLFIRI (Irinotecan + 5-FU) presents on Day 4 post-chemotherapy with 9 watery stools in 24 hours, weakness, orthostatic dizziness, and serum potassium of $3.1\text{ mEq/L}$.
Care Plan Analysis:
- CTCAE Grading: 9 stools/day over baseline equals CTCAE Grade 3 Diarrhea.
- Pathophysiology: Delayed secretomotor diarrhea caused by SN-38 metabolite.
- Intervention: Immediately initiate high-dose loperamide (4 mg initial, 2 mg q2h). Admit for IV isotonic saline hydration with $20\text{ mEq KCL/L}$. If diarrhea continues >24 hours, add Octreotide $150\text{ mcg SubQ TID}$. Provide isotonic ORS and low-fat, low-insoluble fiber diet.
A patient receiving Irinotecan chemotherapy experiences profuse watery diarrhea, abdominal cramps, diaphoresis, and excessive salivation 40 minutes into their IV infusion. What is the underlying mechanism and mandatory initial medical intervention?
Under the CTCAE v5.0 grading system for chemotherapy-induced diarrhea, which clinical description corresponds to Grade 3 severity?
What is the primary pathophysiological driver of Late Dumping Syndrome occurring 1 to 3 hours postprandially in patients following subtotal gastrectomy?
Which MNT dietary prescription is indicated during the acute phase of Radiation Enteritis in a patient receiving pelvic radiation therapy?